Richard S. Geary, EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS), sold 50,978 shares at $75.01 ($3.9M) on 2025-11-05, disclosed to the SEC on 2025-11-07.
Scheduled sale ($3.9M) by EVP, Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.01 | 801 | $60K | 1.6% |
| 2 | $75.01 | 800 | $60K | 1.6% |
| 3 | $75.01 | 801 | $60K | 1.6% |
| 4 | $75.01 | 800 | $60K | 1.6% |
| 5 | $75.42 | 18,300 | $1.4M | 35.7% |
| 6 | $76.10 | 14,738 |
| $1.1M |
| 29.0% |
| 7 | $76.10 | 14,738 | $1.1M | 29.0% |
| Total | $75.79 avg | 50,978 | $3.9M | 100% |
| Filing → |
| IONS | SELL | 2025-10-01 | $7.6M | — | Filing → |
| IONS | SELL | 2025-09-04 | $504K | — | Filing → |
| IONS | SELL | 2025-08-06 | $429K | — | Filing → |